**CA2483561072 - Common Stock - After market: 1.06 +0.01 (+0.95%)**

We assign a fundamental rating of **3** out of 10 to **DNN**. **DNN** was compared to 385 industry peers in the **Oil, Gas & Consumable Fuels** industry. While **DNN** has a great health rating, but there are worries on its profitability. **DNN** has a expensive valuation and it also scores bad on growth

ROA (2.78%) VS Industry: 15% outperformed.

0.06

1,708.00

ROE (3.29%) VS Industry: 7% outperformed.

0.30

19,161.80

Profit Margin (84.71%) VS Industry: 91% outperformed.

0.07

334.14

With a price book ratio of **2.70**, **DNN** is valued correctly.

With a **Price/Earnings Ratio** of **105.00**, **DNN** can be considered very expensive at the moment.

Compared to an average industry **Price/Earning Ratio** of **5.76**, **DNN** is valued more expensive than its industry peers. On top of this 99% of the companies listed in the same industry are cheaper than **DNN**!

The **Forward Price/Earnings Ratio** is negative for **DNN**. No positive earnings are expected for the next year.

The high **PEG Ratio**, which compensates the Price/Earnings for growth, indicates **DNN** does not grow enough to justify the current Price/Earnings ratio.

When comparing the price book ratio of **DNN** to the average industry price book ratio of 1.45, **DNN** is valued more expensive than its industry peers.

Price/Earnings (105) VS Industry: 1% outperformed.

4,750.00

0.01

Price/Book (2.7) VS Industry: 23% outperformed.

3,984.80

0.04

The **Earnings Per Share** has been growing slightly by **0.00%** over the past year.

Measured over the past 5 years, **DNN** shows a small growth in **Revenue**. The Revenue has been growing by **1.03%** on average per year.

Based on estimates for the next 5 years, **DNN** will show a decrease in **Revenue**. The Revenue will decrease by **-8.16%** on average per year.

Based on estimates for the next 5 years, **DNN** will show a very negative growth in **Earnings Per Share**. The EPS will decrease by **-73.49%** on average per year.

Looking at the last year, **DNN** shows a very negative growth in **Revenue**. The Revenue has decreased by **-15.29%** in the last year.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.

Past | Future | ||||||
---|---|---|---|---|---|---|---|

5Y | 3Y | 1Y | 1Y | 2Y | 3Y | 5Y | |

EPS | N/A | N/A | 0% | -251.5% | -73.49% | N/A | N/A |

Revenue | 1.03% | 3.02% | -15.29% | -17.07% | -8.16% | N/A | N/A |

The Current Ratio of **DNN** is much better than the industry average of **1.17**. **DNN** has a better rating than **81%** of its industry peers.

The Quick Ratio of **DNN** is much better than the industry average of **1.01**. **DNN** has a better rating than **82%** of its industry peers.

With a Debt to Equity ratio of **0.00**, **DNN** is doing better than the averages in the industry. The industry average is at **0.25**.

An Altman-Z score of **5.31** indicates that **DNN** is not in any danger for bankruptcy at the moment.

The Altman-Z score of **DNN** is much better than the industry average of **2.05**. **DNN** has a better rating than **85%** of its industry peers.

Debt/Equity (0) VS Industry: 77% outperformed.

78.08

0.00

Quick Ratio (3.5) VS Industry: 82% outperformed.

0.00

279.52

Current Ratio (3.65) VS Industry: 81% outperformed.

0.00

279.52

Altman-Z (5.31) VS Industry: 85% outperformed.

-283,883.16

804.85

NYSEARCA:DNN (3/29/2023, 7:04:00 PM)**+0.03 (+2.94%) **

Chartmill FA Rating

GICS SectorEnergy

GICS IndustryGroupEnergy

GICS IndustryOil, Gas & Consumable Fuels

Earnings (Last)03-09 2023-03-09/amc

Earnings (Next)05-02 2023-05-02/amc

Inst Owners28.92%

Inst Owner Change4.28%

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap863.74M

Analysts80

Price Target1.81 (72.38%)

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | N/A |

Dividend Growth(5Y)N/A

DPN/A

Div Incr YearsN/A

Div Non Decr YearsN/A

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)50.5%

Min EPS beat(2)0.99%

Max EPS beat(2)100%

EPS beat(4)3

Avg EPS beat(4)149.51%

Min EPS beat(4)-98.02%

Max EPS beat(4)595.05%

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

PT rev (1m)-0.28%

PT rev (3m)0.62%

EPS NQ rev (1m)0%

EPS NQ rev (3m)0%

EPS NY rev (1m)-300%

EPS NY rev (3m)-300%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)4.68%

Revenue NY rev (3m)4.68%

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 105 | ||

Fwd PE | N/A | ||

P/S | 69.6 | ||

P/FCF | N/A | ||

P/OCF | N/A | ||

P/B | 2.7 | ||

P/tB | 2.7 | ||

EV/EBITDA | N/A |

EPS(TTM)0.01

EY0.95%

EPS(NY)-0.02

Fwd EYN/A

FCF(TTM)-0.03

FCFYN/A

OCF(TTM)-0.03

OCFYN/A

SpS0.02

BVpS0.39

TBVpS0.39

PEG (NY)N/A

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 2.78% | ||

ROE | 3.29% | ||

ROIC | N/A | ||

ROICexc | N/A | ||

ROICexgc | N/A | ||

OM | N/A | ||

PM | 84.71% | ||

GM | 34.52% |

ROICexgc(3y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc(3y)N/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y69.44%

GM growth 5Y19.3%

F-Score1

Asset Turnover0.03

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0 | ||

Debt/FCF | N/A | ||

Debt/EBITDA | N/A | ||

Cap/Depr | 79.25% | ||

Profit Quality | N/A | ||

Current Ratio | 3.65 | ||

Quick Ratio | 3.5 | ||

Altman-Z | 5.31 |

F-Score1

WACC10.16%

ROIC/WACCN/A

Cap/Depr(3y)33.28%

Cap/Depr(5y)25.76%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

Growth

EPS 1Y0%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q100%

EPS Next Y-251.5%

EPS Next 2Y-73.49%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue growth 1Y-15.29%

Revenue growth 3Y3.02%

Revenue growth 5Y1.03%

Revenue growth Q2Q-10.79%

Revenue Next Year-17.07%

Revenue Next 2Y-8.16%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-76.49%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year-86.29%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-55.79%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-32.47%

OCF growth 3YN/A

OCF growth 5YN/A

*Find stocks with similar Fundamental rating on the USA*

*Find the competitors with the best fundamentals on the USA*

*Find the competitors with the best valuation on the USA*

*Find the competitors with the best dividend on the USA*